TFF Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
TFF Pharmaceuticals has a total shareholder equity of $9.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $12.0M and $2.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$5.48m |
Equity | US$9.57m |
Total liabilities | US$2.46m |
Total assets | US$12.03m |
Recent financial health updates
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?
Apr 10Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?
Sep 27We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully
May 17Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation
Jan 06Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth
Sep 16Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth
Mar 30Recent updates
Can TFF Pharmaceuticals (NASDAQ:TFFP) Afford To Invest In Growth?
Apr 10Is TFF Pharmaceuticals (NASDAQ:TFFP) In A Good Position To Deliver On Growth Plans?
Sep 27TFF Pharma: The Potential Is Still Very Much Present
Aug 29TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways
Aug 09TFF Pharmaceuticals expands R&D operations with new Austin facility
Jul 14TFF Pharmaceuticals: A Highly Attractive Basket Of Options
May 23We Think TFF Pharmaceuticals (NASDAQ:TFFP) Needs To Drive Business Growth Carefully
May 17Here's Why We're Not Too Worried About TFF Pharmaceuticals' (NASDAQ:TFFP) Cash Burn Situation
Jan 06TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But Timidly
Dec 02Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth
Sep 16TFF Pharmaceuticals: Cautiously Optimistic
Sep 09TFF Pharma's Platform Is Highly Relevant In The Battle Against The Pandemic
Jul 27TFF Pharmaceuticals: Looking Attractive At These Prices
Jun 03Companies Like TFF Pharmaceuticals (NASDAQ:TFFP) Are In A Position To Invest In Growth
Mar 30Financial Position Analysis
Short Term Liabilities: TFFP's short term assets ($7.6M) exceed its short term liabilities ($2.4M).
Long Term Liabilities: TFFP's short term assets ($7.6M) exceed its long term liabilities ($31.7K).
Debt to Equity History and Analysis
Debt Level: TFFP is debt free.
Reducing Debt: TFFP has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TFFP has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: TFFP is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.